Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioningJunya Kanda, David A Rizzieri, Cristina Gasparetto, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.Cancer Investigation|December 21, 2010
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donorsDavid A Rizzieri, Christopher Crout, Robert Storms, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2017
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and HospitalizationSarah Anand, Samantha Thomas, Terry Hyslop, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Clinical and Neuroimaging Correlates of Post-Transplant DeliriumPatrick Smith, Jillian C Thompson, Elena Perea, et al.Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.Annals of the Rheumatic Diseases|October 14, 2022
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosisJulia Z Adamska, Amin Zia, Michelle S Bloom, et al.JAMA Dermatology|April 18, 2019
Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host DiseaseAdela R Cardones, Keith M Sullivan, Cindy Green, et al.Journal of Hematology & Oncology|August 19, 2016
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryMichael M B Green, Nelson Chao, Saurabh Chhabra, et al.Pageof 7